Insider Transactions in Q4 2024 at Emergent Bio Solutions Inc. (EBS)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2024
|
Simon C Lowry SVP, R&D, CMO |
BUY
Grant, award, or other acquisition
|
Direct |
29,482
+50.0%
|
-
|
|
Dec 08
2024
|
Coleen Glessner EVP, Quality & Ethics, and CPL |
SELL
Payment of exercise price or tax liability
|
Direct |
18,674
-11.45%
|
$168,066
$9.01 P/Share
|
|
Nov 12
2024
|
Donald W De Golyer Director |
SELL
Open market or private sale
|
Direct |
25,000
-18.37%
|
$250,000
$10.91 P/Share
|
|
Nov 11
2024
|
William Hartzel SVP, Bioservices |
SELL
Payment of exercise price or tax liability
|
Direct |
632
-1.31%
|
$6,952
$11.97 P/Share
|
|
Nov 11
2024
|
Marvin L White Director |
SELL
Open market or private sale
|
Direct |
14,287
-20.89%
|
$157,157
$11.97 P/Share
|
|
Oct 15
2024
|
Richard S Lindahl EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+8.06%
|
-
|